The power of HLA-G +3142G/C genetic variants to predict the metastatic-free survival among breast cancer patients was investigated by comparing patients carrying no risk allele (GG) versus those carrying at least one risk allele (CC and CG) (Figure 4). The gene discussed is HLA-G; the disease is breast cancer.